These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 2123130
1. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia. Montenero AS, Natale A, di Bona G, Calvi V, Santarelli P, Manzoli U. Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130 [Abstract] [Full Text] [Related]
2. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia]. Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F. G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857 [Abstract] [Full Text] [Related]
3. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS, Bhargava M, Arora R, Khalilullah M. Indian Heart J; 1995 May; 47(3):237-43. PubMed ID: 7558090 [Abstract] [Full Text] [Related]
4. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994 [Abstract] [Full Text] [Related]
5. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy]. Sarubbi B, Ducceschi V, Esposito R, Briglia N, Manzo G, Mayer MS, Santangelo L, Iacono A. Cardiologia; 1996 Jun 20; 41(6):543-9. PubMed ID: 8766417 [Abstract] [Full Text] [Related]
6. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E. G Ital Cardiol; 1987 Aug 20; 17(8):690-8. PubMed ID: 3121426 [Abstract] [Full Text] [Related]
7. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?]. Inama G, Furlanello F, Braito G, Guarnerio M, Vergara G. G Ital Cardiol; 1991 Feb 20; 21(2):131-8. PubMed ID: 1907937 [Abstract] [Full Text] [Related]
8. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL. Minerva Cardioangiol; 1995 Oct 20; 43(10):449-57. PubMed ID: 8819814 [Abstract] [Full Text] [Related]
9. Partial reversal by exercise of protective effect in atrial fibrillation inducibility in patients with an accessory atrioventricular connection: comparison between flecainide and propafenone. Auricchio A, Auricchio U, Chiariello L. G Ital Cardiol; 1994 Feb 20; 24(2):131-6. PubMed ID: 8013765 [Abstract] [Full Text] [Related]
10. [Adenosine triphosphate for supraventricular tachycardia in newborns and suckling infants]. Haas NA, Pufahl C, König SA, Gessler P, Teufel M. Dtsch Med Wochenschr; 1994 Oct 07; 119(40):1351-6. PubMed ID: 7924940 [Abstract] [Full Text] [Related]
11. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF. Arch Mal Coeur Vaiss; 1985 Oct 07; 78 Spec No():81-90. PubMed ID: 3938264 [Abstract] [Full Text] [Related]
12. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia]. Song Y. Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 07; 19(6):361-3, 397. PubMed ID: 1821351 [Abstract] [Full Text] [Related]
13. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome]. Kieny JR, Kraenner C, Facello A, Roul G, Mossard JM, Bareiss P, Sacrez A. Arch Mal Coeur Vaiss; 1989 Sep 07; 82(9):1585-93. PubMed ID: 2510679 [Abstract] [Full Text] [Related]
14. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. Delise P, D'Este D, Bonso A, Allibardi P, Raviele A, Di Pede F, Piccolo E. G Ital Cardiol; 1989 Dec 07; 19(12):1094-104. PubMed ID: 2576799 [Abstract] [Full Text] [Related]
15. Flecainide as first-line treatment for supraventricular tachycardia in newborns. Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB. J Cardiovasc Med (Hagerstown); 2009 May 07; 10(5):372-5. PubMed ID: 19300276 [Abstract] [Full Text] [Related]
16. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration]. Nishino T. Hokkaido Igaku Zasshi; 1989 Nov 07; 64(6):738-48. PubMed ID: 2606448 [Abstract] [Full Text] [Related]
17. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge]. Hernández González D, Iturralde Torres P, Romero L, Colín L, Villarreal A, González Hermosillo JA. Arch Inst Cardiol Mex; 1990 Nov 07; 60(2):175-81. PubMed ID: 2378538 [Abstract] [Full Text] [Related]
18. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation]. Fauchier JP, Cosnay P, Moquet B, Rouesnel P, Kapusta P, Vrancea F. Arch Mal Coeur Vaiss; 1986 Sep 07; 79(10):1506-14. PubMed ID: 3099684 [Abstract] [Full Text] [Related]
19. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases]. Denjoy I, Lucet V, Do Ngoc D, Magnier S, Casasoprana A, Coumel P. Arch Mal Coeur Vaiss; 1991 May 07; 84(5):647-52. PubMed ID: 1910326 [Abstract] [Full Text] [Related]
20. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]